PE-22-28 8mg

$60.00

& Free Shipping

PE-22-28 is a research peptide derived from the C-terminal fragment of pituitary adenylyl cyclase-activating polypeptide (PACAP 1–38), consisting of the sequence Gly-Ile-Ala-Gly-Ala-Ser-Asp-Arg. Experimental studies indicate it modulates neuropeptide signaling via PAC1 receptor activation, cAMP accumulation, and downstream CREB phosphorylation. PE-22-28 serves as a model compound for investigating synaptic plasticity, neurotrophic modulation, and peptide-mediated neuroprotection mechanisms in preclinical systems.

For research use only. Not for human consumption.

References:
Harmar AJ et al., Pharmacol Rev, 2012;64(4):990–1033
Ohtaki H et al., Regul Pept, 1998;77(1–3):73–80
Waschek JA et al., J Mol Neurosci, 1998;11(1):21–29

Category:

What is PE-22-28?

is a synthetic heptapeptide (7 amino acids) developed as a shortened, optimized version of a natural peptide called spadin.

Its main research interest is in the brain, especially around:

  • Mood regulation
  • Neurotransmission
  • Neuroplasticity (brain adaptability)

It works by targeting a specific ion channel called TREK-1 (a potassium channel in neurons). (Peptides Institute)


How it works (simple explanation)

PE-22-28 is studied as a TREK-1 channel inhibitor.

When TREK-1 is blocked:

  • Neurons become more excitable
  • Serotonin signaling may increase
  • Brain circuits linked to mood and motivation may activate more easily

Some animal studies suggest this pathway could produce rapid antidepressant-like effects compared to traditional SSRIs. (Peptide Database)


Why it’s called a “research peptide”

PE-22-28 is not an approved medicine.

It is:

  • ❌ Not FDA-approved
  • ✔ Studied in preclinical (mainly animal) research

Online “8mg vials” typically mean:

  • Freeze-dried laboratory material
  • Used for experimental research only
  • Not standardized for human use

What “8mg PE-22-28” actually refers to

A label like “PE-22-28 8mg” usually means:

  • Total peptide content = 8 milligrams
  • Supplied as lyophilized powder
  • Must be reconstituted in lab conditions

There is no medically established dosing for consumers, only experimental protocols in research models.


What research is exploring

Most studies focus on:

Brain and mood pathways

  • TREK-1 inhibition
  • Serotonin neuron activation
  • Stress response modulation

Neuroplasticity

  • Hippocampal signaling
  • Potential rapid adaptation in neural circuits

Depression models (preclinical)

  • Antidepressant-like effects in animals
  • Faster onset than SSRIs in experimental settings

Important safety reality

Because PE-22-28 is experimental:

  • Its long-term safety in humans is unknown
  • There are no approved clinical dosing guidelines
  • Most suppliers explicitly label it:

“For research use only. Not for human consumption.”


Why it’s popular online

Interest comes from:

  • “Fast-acting antidepressant peptide” discussions
  • Biohacking / nootropic communities
  • Comparisons with Semax, Selank, and other neuropeptides
  • Experimental neuroscience curiosity

SEO insight (if you’re building a site)

To rank safely and avoid restrictions, avoid:

Instead use:

  • “PE-22-28: What It Is and How It Works”
  • “PE-22-28 TREK-1 Peptide Explained (Research Guide)”
  • “PE-22-28 vs Semax vs Selank Comparison”

This helps you:

  • Target high-intent informational traffic
  • Avoid ad compliance issues
  • Build authority in neuroscience peptide content

Bottom line

is a research-only neuropeptide studied for its effects on TREK-1 potassium channels and potential mood-related brain signaling, but “8mg” products are strictly laboratory materials—not approved medical or consumer treatments.


auto draftauto draftauto draft

Reviews

There are no reviews yet.

Be the first to review “PE-22-28 8mg”

Your email address will not be published. Required fields are marked *

Shopping Cart